You just read:

DelMar Pharmaceuticals Receives Additional Non-Dilutive Funding from the Government of Canada to Support Expanded Research with Lead Product Candidate VAL-083

News provided by

DelMar Pharmaceuticals, Inc.

Jan 09, 2017, 08:30 ET